Philadelphia[1]’s street opioid supply – or “dope” market – is constantly changing. As health care workers[2] and researchers[3] who care for people who use drugs in our community, we have witnessed these shifts firsthand.
New adulterants are frequently added to the mix. They bring additional and often uncertain risks for people who use drugs, and new challenges for the health care providers and systems who treat them....